Xiang-Dong Cheng (Xiangdong Cheng)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Nature communications

Journal of oncology

Journal of cellular and molecular medicine

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Hanning Ying, Xiaoqing Liu, Min Zhang, Yiyue Ren, Shihui Zhen, Xiaojie Wang, Bo Liu, Peng Hu, Lian Duan, Mingzhi Cai, Ming Jiang, Xiang-Dong Cheng, Xiang-Yang Gong, Haitao Jiang, Jianshuai Jiang, Jianjun Zheng, Kelei Zhu, Wei Zhou, Baochun Lu, Hongkun Zhou, Yiyu Shen, Jinlin Du, Mingliang Ying, Qiang Hong, Jingang Mo, Jianfeng Li, Guanxiong Ye, Shizheng Zhang, Hongjie Hu, Jihong Sun, Hui Liu, Yiming Li, Xingxin Xu, Huiping Bai, Shuxin Wang, Xin Cheng, Xiaoyin Xu, Long Jiao, Risheng Yu, Wan Yee Lau, Yizhou Yu, Xiujun Cai
A multicenter clinical AI system study for detection and diagnosis of focal liver lesions. Nature communications 15 (1) (2024)
Hanning Ying, Xiaoqing Liu, Min Zhang, Yiyue Ren, Shihui Zhen, Xiaojie Wang, Bo Liu, Peng Hu, Lian Duan, Mingzhi Cai, Ming Jiang, Xiang-Dong Cheng, Xiang-Yang Gong, Haitao Jiang, Jianshuai Jiang, Jianjun Zheng, Kelei Zhu, Wei Zhou, Baochun Lu, Hongkun Zhou, Yiyu Shen, Jinlin Du, Mingliang Ying, Qiang Hong, Jingang Mo, Jianfeng Li, Guanxiong Ye, Shizheng Zhang, Hongjie Hu, Jihong Sun, Hui Liu, Yiming Li, Xingxin Xu, Huiping Bai, Shuxin Wang, Xin Cheng, Xiaoyin Xu, Long Jiao, Risheng Yu, Wan Yee Lau, Yizhou Yu, Xiujun Cai
A multicenter clinical AI system study for detection and diagnosis of focal liver lesions. Nature communications 15 (1) (2024)
Hanning Ying, Xiaoqing Liu, Min Zhang, Yiyue Ren, Shihui Zhen, Xiaojie Wang, Bo Liu, Peng Hu, Lian Duan, Mingzhi Cai, Ming Jiang, Xiang-Dong Cheng, Xiang-Yang Gong, Haitao Jiang, Jianshuai Jiang, Jianjun Zheng, Kelei Zhu, Wei Zhou, Baochun Lu, Hongkun Zhou, Yiyu Shen, Jinlin Du, Mingliang Ying, Qiang Hong, Jingang Mo, Jianfeng Li, Guanxiong Ye, Shizheng Zhang, Hongjie Hu, Jihong Sun, Hui Liu, Yiming Li, Xingxin Xu, Huiping Bai, Shuxin Wang, Xin Cheng, Xiaoyin Xu, Long Jiao, Risheng Yu, Wan Yee Lau, Yizhou Yu, Xiujun Cai
A multicenter clinical AI system study for detection and diagnosis of focal liver lesions. Nature communications 15 (1) (2024)
Hanning Ying, Xiaoqing Liu, Min Zhang, Yiyue Ren, Shihui Zhen, Xiaojie Wang, Bo Liu, Peng Hu, Lian Duan, Mingzhi Cai, Ming Jiang, Xiang-Dong Cheng, Xiang-Yang Gong, Haitao Jiang, Jianshuai Jiang, Jianjun Zheng, Kelei Zhu, Wei Zhou, Baochun Lu, Hongkun Zhou, Yiyu Shen, Jinlin Du, Mingliang Ying, Qiang Hong, Jingang Mo, Jianfeng Li, Guanxiong Ye, Shizheng Zhang, Hongjie Hu, Jihong Sun, Hui Liu, Yiming Li, Xingxin Xu, Huiping Bai, Shuxin Wang, Xin Cheng, Xiaoyin Xu, Long Jiao, Risheng Yu, Wan Yee Lau, Yizhou Yu, Xiujun Cai
A multicenter clinical AI system study for detection and diagnosis of focal liver lesions. Nature communications 15 (1) (2024)
Hanning Ying, Xiaoqing Liu, Min Zhang, Yiyue Ren, Shihui Zhen, Xiaojie Wang, Bo Liu, Peng Hu, Lian Duan, Mingzhi Cai, Ming Jiang, Xiang-Dong Cheng, Xiang-Yang Gong, Haitao Jiang, Jianshuai Jiang, Jianjun Zheng, Kelei Zhu, Wei Zhou, Baochun Lu, Hongkun Zhou, Yiyu Shen, Jinlin Du, Mingliang Ying, Qiang Hong, Jingang Mo, Jianfeng Li, Guanxiong Ye, Shizheng Zhang, Hongjie Hu, Jihong Sun, Hui Liu, Yiming Li, Xingxin Xu, Huiping Bai, Shuxin Wang, Xin Cheng, Xiaoyin Xu, Long Jiao, Risheng Yu, Wan Yee Lau, Yizhou Yu, Xiujun Cai
A multicenter clinical AI system study for detection and diagnosis of focal liver lesions. Nature communications 15 (1) (2024)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Zhiyuan Xu, Yida Huang, Can Hu, Lingbin Du, Yi-An Du, Yanqiang Zhang, Jiangjiang Qin, Wanshan Liu, Ruimin Wang, Shouzhi Yang, Jiao Wu, Jing Cao, Juxiang Zhang, Gui-Ping Chen, Hang Lv, Ping Zhao, Weiyang He, Xiaoliang Wang, Min Xu, Pingfang Wang, Chuanshen Hong, Li-Tao Yang, Jingli Xu, Jiahui Chen, Qing Wei, Ruolan Zhang, Li Yuan, Kun Qian, Xiang-Dong Cheng
Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study. Gut (2023)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Pengcheng Yu, Weiyang He, Yanqiang Zhang, Xiang-Dong Cheng, Yue Wu, Yi Wang, Zhehan Bao, Yuhang Xia, Ruolan Zhang, Mengxuan Cao, Li Yuan, Xiang-Dong Cheng, Zhiyuan Xu
SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. Journal of oncology 2022 (2022)
Yunfu Shi, Li Yuan, Jingli Xu, Handong Xu, Lijing Wang, Ling Huang, Zhiyuan Xu, Xiang-Dong Cheng
Huaier Inhibits Gastric Cancer Growth and Hepatic Metastasis by Reducing Syntenin Expression and STAT3 Phosphorylation. Journal of oncology 2022 (2022)
Xiao-Feng Wang, Can Hu, Shao-Wei Mo, Jing-Li Xu, Yan Liu, Han-Dong Xu, Li Yuan, Ling Huang, Jian-Fa Yu, Xiang-Dong Cheng, Zhi-Yuan Xu
GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier. Journal of oncology 2022 (2022)
Zhehan Bao, Yanqiang Zhang, Pengcheng Yu, Yi Wang, Xiang-Dong Cheng, Yuhang Xia, Li Yuan, Zhi-Yuan Xu, Xiang-Dong Cheng
High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Jinwen Shen, Xiu Zhu, Yian Du, Yuan Zhu, Pengfei Yu, Litao Yang, Zhiyuan Xu, Ling Huang, Yunli Zhang, Yanqiang Zhang, Luying Liu, Xiang-Dong Cheng
Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG). Trials 22 (1) (2021)
Xiaofeng Wang, Zhiyuan Xu, Jiancheng Sun, Hang Lv, Yiping Wang, Yixiu Ni, Shangqi Chen, Can Hu, Lijing Wang, Wei Chen, Xiang-Dong Cheng
Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition. Journal of cellular and molecular medicine 24 (6) (2020)
Zhiyuan Xu, Xiang-Dong Cheng, Shangqi Chen, Chunli Zhang, Jianfa Yu, Xiaofeng Wang, Hang Lv, Xiang-Dong Cheng
Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil. Cancer management and research 11 (2019)
Can Hu, Zhiyuan Xu, Shangqi Chen, Hang Lv, Yiping Wang, Xiaofeng Wang, Shaowei Mo, Chengwei Shi, Shenyu Wei, Liqiang Hu, Wei Chen, Xiang-Dong Cheng
Overexpression of B7H5/CD28H is associated with worse survival in human gastric cancer. Journal of cellular and molecular medicine 24 (2) (2019)

Xiang-Dong Cheng.css-eqlu8i{font-size:small;padding-left:4px;} (Xiangdong Cheng)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiang-Dong Cheng (Xiangdong Cheng)